“effectiveness of pulmonary rehabilitation (pr) in copd patients with emphysema phenotype”
DESCRIPTION
Meeting Dipartimento ad Attività Integrata di Oncologia, Ematologia e Patologie dell’ Apparato Respiratorio Direttore Prof. Leonardo Fabbri MODENA, 16 Luglio 2011. “EFFECTIVENESS OF PULMONARY REHABILITATION (PR) IN COPD PATIENTS WITH EMPHYSEMA PHENOTYPE”. A. Iattoni – E. Crisafulli. FENOTIPI. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: “EFFECTIVENESS OF PULMONARY REHABILITATION (PR) IN COPD PATIENTS WITH EMPHYSEMA PHENOTYPE”](https://reader035.vdocuments.us/reader035/viewer/2022081603/568153a3550346895dc1a831/html5/thumbnails/1.jpg)
Villa Pineta s.r.l. Ospedale Privato Accreditato
“EFFECTIVENESS OF PULMONARY REHABILITATION (PR) IN COPD PATIENTS
WITH EMPHYSEMA PHENOTYPE”
“EFFECTIVENESS OF PULMONARY REHABILITATION (PR) IN COPD PATIENTS
WITH EMPHYSEMA PHENOTYPE”
A. Iattoni – E. CrisafulliA. Iattoni – E. Crisafulli
Meeting Dipartimento ad Attività Integrata di Oncologia, Ematologia e Patologie dell’ Apparato Respiratorio
Direttore Prof. Leonardo FabbriMODENA, 16 Luglio 2011
![Page 2: “EFFECTIVENESS OF PULMONARY REHABILITATION (PR) IN COPD PATIENTS WITH EMPHYSEMA PHENOTYPE”](https://reader035.vdocuments.us/reader035/viewer/2022081603/568153a3550346895dc1a831/html5/thumbnails/2.jpg)
BACKGROUND: FENOTIPI DELLA BPCO
FENOTIPIBRONCHITE
CRONICA
ENFISEMA
![Page 3: “EFFECTIVENESS OF PULMONARY REHABILITATION (PR) IN COPD PATIENTS WITH EMPHYSEMA PHENOTYPE”](https://reader035.vdocuments.us/reader035/viewer/2022081603/568153a3550346895dc1a831/html5/thumbnails/3.jpg)
Adapted from O’Donnell et al. Am J Respir Crit Care Med (2001)Adapted from O’Donnell et al. Am J Respir Crit Care Med (2001)
Ventilation (L/min)Ventilation (L/min)
00
2020
4040
6060
8080
100100
120120
To
tal l
un
g c
apac
ity
(% p
red
)T
ota
l lu
ng
cap
acit
y (%
pre
d)
EELVEELV
IRVIRV
VVTT
HealthHealth
00 1010 2020 3030 4040 5050 6060 7070 8080
ICIC
COPDCOPD
00 1010 2020 3030 4040 5050
ICIC
Ventilation (L/min)Ventilation (L/min)
BACKGROUND: L’IPERINFLAZIONE POLMONARE
![Page 4: “EFFECTIVENESS OF PULMONARY REHABILITATION (PR) IN COPD PATIENTS WITH EMPHYSEMA PHENOTYPE”](https://reader035.vdocuments.us/reader035/viewer/2022081603/568153a3550346895dc1a831/html5/thumbnails/4.jpg)
BACKGROUND: RR RATIONALE
![Page 5: “EFFECTIVENESS OF PULMONARY REHABILITATION (PR) IN COPD PATIENTS WITH EMPHYSEMA PHENOTYPE”](https://reader035.vdocuments.us/reader035/viewer/2022081603/568153a3550346895dc1a831/html5/thumbnails/5.jpg)
BACKGROUND: RR AS PROCESS OF CARE
![Page 6: “EFFECTIVENESS OF PULMONARY REHABILITATION (PR) IN COPD PATIENTS WITH EMPHYSEMA PHENOTYPE”](https://reader035.vdocuments.us/reader035/viewer/2022081603/568153a3550346895dc1a831/html5/thumbnails/6.jpg)
QUALE INTERESSE DI RICERCA ?
1. La RR è efficace per la “malattia” BPCO indipendentemente dal fenotipo clinico
2. I programmi di RR dovrebbero essere “personalizzati” sul paziente secondo le indicazioni degli standard internazionali (ERS/ATS 2006)
3. Non esistono dati in letteratura relativi all’effetto di diversi fenotipi della BPCO sui risultati dei programmi di RR
![Page 7: “EFFECTIVENESS OF PULMONARY REHABILITATION (PR) IN COPD PATIENTS WITH EMPHYSEMA PHENOTYPE”](https://reader035.vdocuments.us/reader035/viewer/2022081603/568153a3550346895dc1a831/html5/thumbnails/7.jpg)
RR IN PAZIENTE CON IPERINFLAZIONE: ANALISI RETROSPETTIVA
![Page 8: “EFFECTIVENESS OF PULMONARY REHABILITATION (PR) IN COPD PATIENTS WITH EMPHYSEMA PHENOTYPE”](https://reader035.vdocuments.us/reader035/viewer/2022081603/568153a3550346895dc1a831/html5/thumbnails/8.jpg)
RR IN PAZIENTE CON IPERINFLAZIONE: ANALISI RETROSPETTIVA
![Page 9: “EFFECTIVENESS OF PULMONARY REHABILITATION (PR) IN COPD PATIENTS WITH EMPHYSEMA PHENOTYPE”](https://reader035.vdocuments.us/reader035/viewer/2022081603/568153a3550346895dc1a831/html5/thumbnails/9.jpg)
RR IN PAZIENTE CON IPERINFLAZIONE: ANALISI RETROSPETTIVA
![Page 10: “EFFECTIVENESS OF PULMONARY REHABILITATION (PR) IN COPD PATIENTS WITH EMPHYSEMA PHENOTYPE”](https://reader035.vdocuments.us/reader035/viewer/2022081603/568153a3550346895dc1a831/html5/thumbnails/10.jpg)
RR IN PAZIENTE CON IPERINFLAZIONE: ANALISI RETROSPETTIVA
![Page 11: “EFFECTIVENESS OF PULMONARY REHABILITATION (PR) IN COPD PATIENTS WITH EMPHYSEMA PHENOTYPE”](https://reader035.vdocuments.us/reader035/viewer/2022081603/568153a3550346895dc1a831/html5/thumbnails/11.jpg)
RR IN PAZIENTE CON IPERINFLAZIONE: ANALISI RETROSPETTIVA
![Page 12: “EFFECTIVENESS OF PULMONARY REHABILITATION (PR) IN COPD PATIENTS WITH EMPHYSEMA PHENOTYPE”](https://reader035.vdocuments.us/reader035/viewer/2022081603/568153a3550346895dc1a831/html5/thumbnails/12.jpg)
RR IN PAZIENTE CON IPERINFLAZIONE: ANALISI RETROSPETTIVA
![Page 13: “EFFECTIVENESS OF PULMONARY REHABILITATION (PR) IN COPD PATIENTS WITH EMPHYSEMA PHENOTYPE”](https://reader035.vdocuments.us/reader035/viewer/2022081603/568153a3550346895dc1a831/html5/thumbnails/13.jpg)
RR IN PAZIENTE CON IPERINFLAZIONE: ANALISI RETROSPETTIVA
● retrospective nature
● other functional indicators (lung diffusion capacity to CO)
● the definition of the LH group, as emphysema-like COPD patients, was exclusively based on the measurement of the residual lung volumes (FRC and RV).
● the functional hypothesis behind the greater change in exercise tolerance, as observed in our LH patients, remains just pure speculation.
STUDY LIMITATIONS
![Page 14: “EFFECTIVENESS OF PULMONARY REHABILITATION (PR) IN COPD PATIENTS WITH EMPHYSEMA PHENOTYPE”](https://reader035.vdocuments.us/reader035/viewer/2022081603/568153a3550346895dc1a831/html5/thumbnails/14.jpg)
OBIETTIVO DELLO STUDIO
To investigate prospectively whether COPD patients with
different disease phenotype (chronic bronchitis vs
pulmonary emphysema) have a different response to PR.
![Page 15: “EFFECTIVENESS OF PULMONARY REHABILITATION (PR) IN COPD PATIENTS WITH EMPHYSEMA PHENOTYPE”](https://reader035.vdocuments.us/reader035/viewer/2022081603/568153a3550346895dc1a831/html5/thumbnails/15.jpg)
![Page 16: “EFFECTIVENESS OF PULMONARY REHABILITATION (PR) IN COPD PATIENTS WITH EMPHYSEMA PHENOTYPE”](https://reader035.vdocuments.us/reader035/viewer/2022081603/568153a3550346895dc1a831/html5/thumbnails/16.jpg)
DISEGNO DELLO STUDIO
PERSPECTIVE
MULTI-CENTRES
OBSERVATIONAL
![Page 17: “EFFECTIVENESS OF PULMONARY REHABILITATION (PR) IN COPD PATIENTS WITH EMPHYSEMA PHENOTYPE”](https://reader035.vdocuments.us/reader035/viewer/2022081603/568153a3550346895dc1a831/html5/thumbnails/17.jpg)
VALUTAZIONE DEL PAZIENTE
![Page 18: “EFFECTIVENESS OF PULMONARY REHABILITATION (PR) IN COPD PATIENTS WITH EMPHYSEMA PHENOTYPE”](https://reader035.vdocuments.us/reader035/viewer/2022081603/568153a3550346895dc1a831/html5/thumbnails/18.jpg)
VALUTAZIONE DEL PAZIENTE
![Page 19: “EFFECTIVENESS OF PULMONARY REHABILITATION (PR) IN COPD PATIENTS WITH EMPHYSEMA PHENOTYPE”](https://reader035.vdocuments.us/reader035/viewer/2022081603/568153a3550346895dc1a831/html5/thumbnails/19.jpg)
VALUTAZIONE DEL PAZIENTE
![Page 20: “EFFECTIVENESS OF PULMONARY REHABILITATION (PR) IN COPD PATIENTS WITH EMPHYSEMA PHENOTYPE”](https://reader035.vdocuments.us/reader035/viewer/2022081603/568153a3550346895dc1a831/html5/thumbnails/20.jpg)
VALUTAZIONE DEL PAZIENTE
![Page 21: “EFFECTIVENESS OF PULMONARY REHABILITATION (PR) IN COPD PATIENTS WITH EMPHYSEMA PHENOTYPE”](https://reader035.vdocuments.us/reader035/viewer/2022081603/568153a3550346895dc1a831/html5/thumbnails/21.jpg)
● APPROVATO DAL COMITATO ETICO
● 350 CASI PREVISTI (50-60 CASI PER OGNI CENTRO PARTECIPANTE)
● 30 CASI RACCOLTI NEL NOSTRO CENTRO
STATO DI AVANZAMENTO